{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:11:25Z","timestamp":1777425085607,"version":"3.51.4"},"reference-count":95,"publisher":"Wiley","issue":"S3","license":[{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Pulmonology"],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Management of infections in patients with cystic fibrosis (CF) presents challenges for healthcare providers, including the eradication of initial acquisition, treatment of acute exacerbations, and chronic infection with suppressive therapy. Inhaled antimicrobial therapy for infections in patients with CF has been used in these capacities, often in an effort to achieve optimal concentrations in sputum for antimicrobial efficacy while mitigating potential toxicities associated with systemic therapy. Unfortunately, there are few commercially available products formulated for inhalation, resulting in the off\u2010label use of other formulations, such as intravenous products, administered via nebulization. This review aims to examine the evidence supporting the efficacy of these off\u2010label formulations for management of acute and chronic infections associated with CF, as well as adverse effects associated with their use.<\/jats:p>","DOI":"10.1002\/ppul.24511","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T19:06:39Z","timestamp":1573585599000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Off\u2010label use of intravenous antimicrobials for inhalation in patients with cystic fibrosis"],"prefix":"10.1002","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1401-5628","authenticated-orcid":false,"given":"Cameron J.","family":"McKinzie","sequence":"first","affiliation":[{"name":"Department of Pharmacy University of North Carolina Medical Center Chapel Hill North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy The Hospital for Sick Children Toronto Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Ehlert","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Fairview Health Services Minneapolis Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison G.","family":"Grisso","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Monroe Carell Jr\u00a0Children's Hospital at Vanderbilt Nashville Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaina","family":"Linafelter","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Children's Mercy Kansas City Kansas City Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Lubsch","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Practice Southern Illinois University Edwardsville School of Pharmacy Edwardsville Missouri"},{"name":"Department of Pharmacy Cardinal Glennon Children's Hospital St Louis Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine E.","family":"O'Brien","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice University of Arkansas for Medical Sciences College of Pharmacy Little Rock Arkansas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice C.","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy The Johns Hopkins Hospital Baltimore Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6620-1727","authenticated-orcid":false,"given":"Brittany A.","family":"Wright","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Care University of Iowa Health Care Iowa City Iowa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Claire","family":"Elson","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Children's Mercy Kansas City Kansas City Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,11,12]]},"reference":[{"key":"e_1_2_13_1_2_1","unstructured":"2018 Novartis Pharmaceuticals East Hanover NJ Tobi (tobramycin) [package insert]"},{"key":"e_1_2_13_1_3_1","unstructured":"Bethkis [package insert].Woodstock IL:Chiesi USA Inc;August 2018."},{"key":"e_1_2_13_1_4_1","unstructured":"2014 Novartis Pharmaceuticals Corporation East Hanover NJ Tobi Podhaler [package insert]"},{"key":"e_1_2_13_1_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901073400104"},{"key":"e_1_2_13_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2010.10.003"},{"key":"e_1_2_13_1_7_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201207-1160OE"},{"key":"e_1_2_13_1_8_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200712-1804OC"},{"key":"e_1_2_13_1_9_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-1421"},{"key":"e_1_2_13_1_10_1","unstructured":"Promixin [package insert]. West Sussex United Kingdom. Profile Pharma Limited;2018."},{"key":"e_1_2_13_1_11_1","unstructured":"Colobreathe [package insert]. The Netherlands. Teva Pharmaceuticals Europe BV;2011."},{"key":"e_1_2_13_1_12_1","volume-title":"(colistimethate sodium) [prescribing information]","author":"Colo\u2010Mycin M","year":"2018"},{"key":"e_1_2_13_1_13_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01079-12"},{"key":"e_1_2_13_1_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2012-202059"},{"key":"e_1_2_13_1_15_1","unstructured":"2018 Insmed Bridgewater NJ Arikayce (amikacin liposome inhalation suspension) [package insert]"},{"key":"e_1_2_13_1_16_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201604-0700OC"},{"key":"e_1_2_13_1_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2012-202230"},{"key":"e_1_2_13_1_18_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201807-1318OC"},{"key":"e_1_2_13_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-7020-6285-8.00143-X"},{"key":"e_1_2_13_1_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-7-2"},{"key":"e_1_2_13_1_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-011-1516-3"},{"key":"e_1_2_13_1_22_1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201307-231OC"},{"key":"e_1_2_13_1_23_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00011-18"},{"key":"e_1_2_13_1_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy034"},{"key":"e_1_2_13_1_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1754.1984.tb00035.x"},{"key":"e_1_2_13_1_26_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/136.6.1445"},{"key":"e_1_2_13_1_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0007-0971(87)90161-6"},{"key":"e_1_2_13_1_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.78.6.540"},{"key":"e_1_2_13_1_29_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.5.9810080"},{"key":"e_1_2_13_1_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.10019"},{"key":"e_1_2_13_1_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1542-4758.2012.00675.x"},{"key":"e_1_2_13_1_32_1","doi-asserted-by":"publisher","DOI":"10.3109\/inf.1974.6.issue-4.07"},{"key":"e_1_2_13_1_33_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365528809090221"},{"key":"e_1_2_13_1_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.1950060207"},{"key":"e_1_2_13_1_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.1950070110"},{"key":"e_1_2_13_1_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.1950070413"},{"key":"e_1_2_13_1_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/31.3.429"},{"key":"e_1_2_13_1_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199306173282403"},{"key":"e_1_2_13_1_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01957914"},{"key":"e_1_2_13_1_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-0496(199802)25:2<88::AID-PPUL3>3.0.CO;2-J"},{"key":"e_1_2_13_1_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-0496(200005)29:5<366::AID-PPUL5>3.0.CO;2-L"},{"key":"e_1_2_13_1_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06124-4"},{"key":"e_1_2_13_1_43_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.122.3.930"},{"key":"e_1_2_13_1_44_1","doi-asserted-by":"publisher","DOI":"10.1086\/429323"},{"key":"e_1_2_13_1_45_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4574"},{"key":"e_1_2_13_1_46_1","unstructured":"Antibiotic Treatment for Cystic Fibrosis. UK Cystic Fibrosis Trust Antibiotic Working Group. Third Edition;2009."},{"key":"e_1_2_13_1_47_1","doi-asserted-by":"publisher","DOI":"10.1155\/2007\/673976"},{"key":"e_1_2_13_1_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91446-2"},{"issue":"32","key":"e_1_2_13_1_49_1","first-page":"321","article-title":"Eradication of recent Pseudomonas aeruginosa isolation: TOBI versus colistin\/ciprofloxacin [conference abstract]. North American Cystic Fibrosis Conference; 2009 Oct 15\u201017; Minneapolis, Minnesota","volume":"44","author":"Proesmans M","year":"2009","journal-title":"Pediatr Pulmonol"},{"key":"e_1_2_13_1_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-0496(199705)23:5<330::AID-PPUL4>3.0.CO;2-O"},{"key":"e_1_2_13_1_51_1","unstructured":"DayAJ WilliamsJ McKeownC BrutonA WellerPHEvaluation of inhaled colomycin in children with cystic fibrosis [conference abstract].Proceedings of the 10th International Cystic Fibrosis Congress. Sydney Australia. Poster R9c03.1988."},{"key":"e_1_2_13_1_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki461"},{"key":"e_1_2_13_1_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2008.06.009"},{"key":"e_1_2_13_1_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2012.03.010"},{"key":"e_1_2_13_1_55_1","doi-asserted-by":"publisher","DOI":"10.2500\/ajra.2013.27.3829"},{"key":"e_1_2_13_1_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2012.11.026"},{"key":"e_1_2_13_1_57_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01705-13"},{"key":"e_1_2_13_1_58_1","doi-asserted-by":"publisher","DOI":"10.1177\/1753465817710596"},{"key":"e_1_2_13_1_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2016.08.014"},{"key":"e_1_2_13_1_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc071717"},{"key":"e_1_2_13_1_61_1","unstructured":"US Food and Drug Administration. FDA Alert 6\/28\/2007. MedWatch Online.www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm124896.htm"},{"key":"e_1_2_13_1_62_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00103-08"},{"key":"e_1_2_13_1_63_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/14.suppl_D.7"},{"key":"e_1_2_13_1_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.10231"},{"key":"e_1_2_13_1_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2009.11.009"},{"issue":"35","key":"e_1_2_13_1_66_1","first-page":"320","article-title":"Safety and pharmacokinetics of inhaled vancomycin in individuals with cystic fibrosis","volume":"47","author":"Jennings MT","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"e_1_2_13_1_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.23519"},{"key":"e_1_2_13_1_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2018.07.005"},{"issue":"35","key":"e_1_2_13_1_69_1","first-page":"342","article-title":"Clinical study of vancomycin hydrochloride inhalation powder (Aerovanc) in healthy volunteers","volume":"47","author":"Jouhikainen T","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"e_1_2_13_1_70_1","first-page":"S149","article-title":"Symposium summaries: S11.4 emerging therapies in cystic fibrosis: aerovanc for the treatment of chronic MRSA","volume":"50","author":"Dasenbrook EC","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"e_1_2_13_1_71_1","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-15-223"},{"key":"#cr-split#-e_1_2_13_1_72_1.1","unstructured":"ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2017 Jun 9 \u2010 Identifier NCT03181932 A Study of AeroVanc for the Treatment of MRSA Infection in CF Patients"},{"key":"#cr-split#-e_1_2_13_1_72_1.2","unstructured":"2018 May 3 [cited 2018 Jul 30]. Available from:http:\/\/clinicaltrials.gov\/ct\/show\/NCT03181932?order=1"},{"key":"e_1_2_13_1_73_1","volume-title":"Mandell, Douglas, and Bennett's Principlies and Practice of Infectious Diseases","author":"Craig WA","year":"2015"},{"key":"e_1_2_13_1_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arbr.2012.07.012"},{"key":"e_1_2_13_1_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.1996.tb00212.x"},{"key":"e_1_2_13_1_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-1993(08)60178-2"},{"key":"e_1_2_13_1_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2013.04.013"},{"key":"e_1_2_13_1_78_1","doi-asserted-by":"publisher","DOI":"10.4172\/2332-0877.1000335"},{"key":"e_1_2_13_1_79_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2012-202678.334"},{"key":"e_1_2_13_1_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-1993(15)30290-3"},{"key":"e_1_2_13_1_81_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00296-11"},{"key":"e_1_2_13_1_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1369-5274(99)00008-9"},{"key":"e_1_2_13_1_83_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201008-1293OC"},{"key":"e_1_2_13_1_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2014.12.013"},{"key":"e_1_2_13_1_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2015.12.004"},{"key":"e_1_2_13_1_86_1","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2013.1056"},{"key":"e_1_2_13_1_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2013.08.003"},{"key":"e_1_2_13_1_88_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2015-000100"},{"key":"e_1_2_13_1_89_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00146707"},{"key":"e_1_2_13_1_90_1","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/376287"},{"key":"e_1_2_13_1_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2012.09.018"},{"key":"e_1_2_13_1_92_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.12.4.501"},{"key":"e_1_2_13_1_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2013.10.014"},{"key":"e_1_2_13_1_94_1","unstructured":"Pulmatrix Announces Positive Top\u2010Line Results from Parts 1 and 2 of the 3\u2010Part Phase 1\/1b Clinical Trial of Pulmazole \u2010 an Inhaled Dry\u2010Powder iSPERSE\u2122 Formulation of Itraconazole;2018. Available at:https:\/\/ir.pulmatrix.com\/2018\u201006\u201025\u2010Pulmatrix\u2010Announces\u2010Positive\u2010Top\u2010Line\u2010Results\u2010from\u2010Parts\u20101\u2010and\u20102\u2010of\u2010the\u20103\u2010Part\u2010Phase\u20101\u20101b\u2010Clinical\u2010Trial\u2010of\u2010Pulmazole\u2010an\u2010Inhaled\u2010Dry\u2010Powder\u2010iSPERSE\u2010TM\u2010Formulation\u2010of\u2010Itraconazole. Accessed October 1 2018."},{"key":"e_1_2_13_1_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2009.06.017"}],"container-title":["Pediatric Pulmonology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fppul.24511","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ppul.24511","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ppul.24511","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ppul.24511","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T10:00:04Z","timestamp":1693994404000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ppul.24511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":95,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["10.1002\/ppul.24511"],"URL":"https:\/\/doi.org\/10.1002\/ppul.24511","archive":["Portico"],"relation":{},"ISSN":["8755-6863","1099-0496"],"issn-type":[{"value":"8755-6863","type":"print"},{"value":"1099-0496","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"2019-03-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}